A new drug for treating late-stage pancreatic cancer was approved on Friday by the FDA.
Used in trial, Abraxane prolonged the lives of patients with about two months.
What is specific for this form of cancer is the advanced stage of the illness when it’s discovered after
an insidious evolution. In most cases, a surgical intervention is not possible and only specific drugs like this new one can be used.
- Written by Robert Woodward
- Category: Medicine